No Picture
Trading Ideas

COCP Stock: Coronavirus Drug Licensing and $11 Million Direct Offering

COCP stock took off early this week and investors are keeping a close watch. However, why did this happen to begin with?
Cocrystal Pharma (Nasdaq: COCP) announced a licensing agreement with the Kansas State University Research Foundation (KSURF) for coronavirus drug candidates. With rising concerns over the virus, Cocrystal is looking to progress its research with preclinical and clinical testing.
Moreover, it announced an $11 million registered direct offering priced at-the-market. Several “institutional investors” are in agreement to purchase 8,461,540 shares of its common stock at a price of $1.30 per share. The direct offering expects to close on or around March …read more […]

No Picture
Trading Ideas

Why the impact of the coronavirus on stocks could be ‘short lived’: Expert

The market selloff is escalating as fears regarding the coronavirus outbreak continue to impact stocks. However, Fross & Fross Wealth Management Co-Founder says that he expects the impact to be “short lived”. He joins Yahoo Finance’s On the Move panel to discuss. …read more […]